Cystic FibrosisReferences
Citations
-
Boat TF, Acton JD (2007). Cystic fibrosis. In RM
Kliegman et al., eds., Nelson Textbook of Pediatrics,
18th ed., pp. 1803–1817. Philadelphia: Saunders Elsevier.
-
Elkins MR, et al. (2006). A controlled trial of
long-term inhaled hypertonic saline in patients with cystic fibrosis.
New England Journal of Medicine, 354(3):
229–240.
-
Wark P, et al. (2005). Nebulised hypertonic saline for
cystic fibrosis. Cochrane Database of Systematic Reviews
(3). Oxford: Update Software.
Other Works Consulted
-
ACOG Committee on Genetics (2002, reaffirmed 2006).
Genetics and molecular testing. ACOG Technology Assessment in Obstetrics and Gynecology, 100(1): 193–211.
-
Boucher RC (2005). Cystic fibrosis. In RJ Mason et
al., eds., Murray and Nadel's Textbook of Respiratory Medicine, 4th ed., vol. 1, pp. 1217–1251. Philadelphia: Elsevier
Saunders.
-
Dovey ME (2006). Cystic fibrosis. In FD Burg et al.,
eds., Current Pediatric Therapy, 18th ed., pp. 457–461.
Philadelphia: Saunders Elsevier.
-
Farrell PM, et al. (2008). Guidelines for diagnosis of
cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation
consensus report. Journal of Pediatrics, 153(2):
S4–S14.
-
Gustafsson PM, et al. (2008). Multiple-breath inert
gas washout and spirometry versus structural lung disease in cystic fibrosis.
Thorax, 63(2): 129–134.
-
Jones AP, et al. (2003). Dornase alfa for cystic
fibrosis. Cochrane Database of Systematic Reviews (3).
Oxford: Update Software.
-
Kerby GS, et al. (2007). Bronchiectasis section of
Respiratory tract and mediastinum. In WW Hay et al., eds., Current Pediatric Diagnosis and Treatment, 18th ed., pp.
509–510. New York: McGraw-Hill.
-
Nash EF, et al. (2009). Nebulized and oral thiol
derivatives for pulmonary disease in cystic fibrosis. Cochrane Database of Systematic Reviews (1).
-
Southern KW, et al. (2009). Newborn screening for
cystic fibrosis. Cochrane Database of Systematic Reviews
(1).
| |